

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | monoubiquitinated protein deubiquitination (GO:0035520) | 7.45125661 |
| 2 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.85669455 |
| 3 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 4.74502294 |
| 4 | negative regulation of membrane potential (GO:0045837) | 4.54976270 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.53792776 |
| 6 | neuron cell-cell adhesion (GO:0007158) | 4.44064815 |
| 7 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.42240612 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.34191488 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.25211248 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.22760677 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.09465324 |
| 12 | protein K48-linked deubiquitination (GO:0071108) | 4.08015723 |
| 13 | vocalization behavior (GO:0071625) | 4.07062620 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.05404440 |
| 15 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.03542465 |
| 16 | protein import into peroxisome matrix (GO:0016558) | 3.99790121 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.96376838 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.93678108 |
| 19 | dendritic spine morphogenesis (GO:0060997) | 3.90245548 |
| 20 | response to gravity (GO:0009629) | 3.90059359 |
| 21 | protein localization to synapse (GO:0035418) | 3.87605328 |
| 22 | glutamate secretion (GO:0014047) | 3.87426580 |
| 23 | presynaptic membrane assembly (GO:0097105) | 3.76038637 |
| 24 | neuron recognition (GO:0008038) | 3.71515976 |
| 25 | kidney mesenchyme development (GO:0072074) | 3.69038159 |
| 26 | layer formation in cerebral cortex (GO:0021819) | 3.66772751 |
| 27 | axonal fasciculation (GO:0007413) | 3.65120622 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.64413621 |
| 29 | behavioral response to nicotine (GO:0035095) | 3.55233812 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 3.54905079 |
| 31 | exploration behavior (GO:0035640) | 3.53804055 |
| 32 | metanephric mesenchyme development (GO:0072075) | 3.52689051 |
| 33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.49664449 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.49137361 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 3.47252291 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.46225303 |
| 37 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.46030363 |
| 38 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.44481262 |
| 39 | presynaptic membrane organization (GO:0097090) | 3.40532931 |
| 40 | serotonin metabolic process (GO:0042428) | 3.40182287 |
| 41 | dendrite morphogenesis (GO:0048813) | 3.36193431 |
| 42 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.35300368 |
| 43 | neuronal action potential propagation (GO:0019227) | 3.30180000 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.28706568 |
| 45 | postsynaptic membrane organization (GO:0001941) | 3.28033371 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.26965716 |
| 47 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.19962994 |
| 48 | magnesium ion transport (GO:0015693) | 3.15089945 |
| 49 | neurotransmitter secretion (GO:0007269) | 3.14930951 |
| 50 | regulation of endothelial cell differentiation (GO:0045601) | 3.13917428 |
| 51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12897419 |
| 52 | transmission of nerve impulse (GO:0019226) | 3.12688602 |
| 53 | innervation (GO:0060384) | 3.10285101 |
| 54 | startle response (GO:0001964) | 3.09683313 |
| 55 | proline transport (GO:0015824) | 3.07755149 |
| 56 | negative regulation of hormone metabolic process (GO:0032351) | 3.04022416 |
| 57 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.03100233 |
| 58 | primary amino compound metabolic process (GO:1901160) | 3.02084286 |
| 59 | long-term synaptic potentiation (GO:0060291) | 3.01829249 |
| 60 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.01791971 |
| 61 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.99084337 |
| 62 | regulation of cardioblast proliferation (GO:0003264) | 2.99084337 |
| 63 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.94801419 |
| 64 | dendritic spine organization (GO:0097061) | 2.94737242 |
| 65 | negative regulation of neurotransmitter transport (GO:0051589) | 2.94217228 |
| 66 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91505620 |
| 67 | smooth muscle tissue development (GO:0048745) | 2.91157295 |
| 68 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.90306923 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90065882 |
| 70 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.88282282 |
| 71 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.88282282 |
| 72 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.87727802 |
| 73 | regulation of neurotransmitter secretion (GO:0046928) | 2.86828091 |
| 74 | synapse assembly (GO:0007416) | 2.86770492 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.85871829 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.84929107 |
| 77 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.81595389 |
| 78 | regulation of synapse structural plasticity (GO:0051823) | 2.80553950 |
| 79 | cerebellar granule cell differentiation (GO:0021707) | 2.79377066 |
| 80 | positive regulation of synapse assembly (GO:0051965) | 2.79059263 |
| 81 | synaptic vesicle endocytosis (GO:0048488) | 2.78497467 |
| 82 | apical protein localization (GO:0045176) | 2.77696124 |
| 83 | regulation of postsynaptic membrane potential (GO:0060078) | 2.77252531 |
| 84 | positive regulation of membrane potential (GO:0045838) | 2.76322531 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 2.76275370 |
| 86 | long-term memory (GO:0007616) | 2.76046334 |
| 87 | neurotransmitter transport (GO:0006836) | 2.75759329 |
| 88 | gamma-aminobutyric acid transport (GO:0015812) | 2.75584096 |
| 89 | auditory behavior (GO:0031223) | 2.75190970 |
| 90 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.73244130 |
| 91 | synapse organization (GO:0050808) | 2.73112131 |
| 92 | prostate gland growth (GO:0060736) | 2.72752427 |
| 93 | vesicle transport along microtubule (GO:0047496) | 2.71853570 |
| 94 | protein localization to peroxisome (GO:0072662) | 2.71763889 |
| 95 | protein targeting to peroxisome (GO:0006625) | 2.71763889 |
| 96 | establishment of protein localization to peroxisome (GO:0072663) | 2.71763889 |
| 97 | dendrite development (GO:0016358) | 2.70853909 |
| 98 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.69675026 |
| 99 | detection of calcium ion (GO:0005513) | 2.67292537 |
| 100 | adaptation of signaling pathway (GO:0023058) | 2.67127180 |
| 101 | regulation of vesicle fusion (GO:0031338) | 2.67008091 |
| 102 | regulation of neurotransmitter transport (GO:0051588) | 2.65967657 |
| 103 | histone deubiquitination (GO:0016578) | 2.65817728 |
| 104 | limb development (GO:0060173) | 2.64628828 |
| 105 | appendage development (GO:0048736) | 2.64628828 |
| 106 | neuronal ion channel clustering (GO:0045161) | 2.64191741 |
| 107 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.63407177 |
| 108 | maternal behavior (GO:0042711) | 2.61732765 |
| 109 | organelle transport along microtubule (GO:0072384) | 2.60920080 |
| 110 | cellular potassium ion homeostasis (GO:0030007) | 2.59900214 |
| 111 | kidney morphogenesis (GO:0060993) | 2.57684196 |
| 112 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.56862420 |
| 113 | inositol phosphate catabolic process (GO:0071545) | 2.56760238 |
| 114 | parental behavior (GO:0060746) | 2.56085305 |
| 115 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.55257795 |
| 116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.55129594 |
| 117 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.54722278 |
| 118 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.54629371 |
| 119 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.53842712 |
| 120 | regulation of synapse assembly (GO:0051963) | 2.53719649 |
| 121 | L-amino acid import (GO:0043092) | 2.53401790 |
| 122 | activation of protein kinase A activity (GO:0034199) | 2.53366851 |
| 123 | regulation of respiratory system process (GO:0044065) | 2.53071463 |
| 124 | learning (GO:0007612) | 2.52143345 |
| 125 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.52083857 |
| 126 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.52028322 |
| 127 | nephron tubule formation (GO:0072079) | 2.51971836 |
| 128 | neuromuscular process controlling balance (GO:0050885) | 2.51633151 |
| 129 | response to auditory stimulus (GO:0010996) | 2.51505949 |
| 130 | endocrine hormone secretion (GO:0060986) | 2.51271078 |
| 131 | mechanosensory behavior (GO:0007638) | 2.50819067 |
| 132 | L-phenylalanine catabolic process (GO:0006559) | 2.50733410 |
| 133 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.50733410 |
| 134 | negative regulation of protein autophosphorylation (GO:0031953) | 2.50160337 |
| 135 | striatum development (GO:0021756) | 2.49317539 |
| 136 | macroautophagy (GO:0016236) | 2.48815136 |
| 137 | cell migration in hindbrain (GO:0021535) | 2.46897318 |
| 138 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.46688920 |
| 139 | behavioral fear response (GO:0001662) | 2.46188499 |
| 140 | behavioral defense response (GO:0002209) | 2.46188499 |
| 141 | positive regulation of synapse maturation (GO:0090129) | 2.44729128 |
| 142 | epithelial cilium movement (GO:0003351) | 2.44267006 |
| 143 | regulation of respiratory gaseous exchange (GO:0043576) | 2.44249764 |
| 144 | fear response (GO:0042596) | 2.43983176 |
| 145 | cochlea development (GO:0090102) | 2.43683122 |
| 146 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.42597504 |
| 147 | cobalamin metabolic process (GO:0009235) | 2.42294537 |
| 148 | activin receptor signaling pathway (GO:0032924) | 2.42198250 |
| 149 | peroxisome organization (GO:0007031) | 2.41605817 |
| 150 | inner ear receptor cell development (GO:0060119) | 2.40821944 |
| 151 | positive regulation of potassium ion transport (GO:0043268) | 2.40392831 |
| 152 | axonemal dynein complex assembly (GO:0070286) | 2.40085562 |
| 153 | regulation of dendritic spine development (GO:0060998) | 2.39958892 |
| 154 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.39768033 |
| 155 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.39760364 |
| 156 | central nervous system neuron axonogenesis (GO:0021955) | 2.39721151 |
| 157 | L-phenylalanine metabolic process (GO:0006558) | 2.39260046 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.39260046 |
| 159 | regulation of neurotransmitter uptake (GO:0051580) | 2.38637766 |
| 160 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.38157515 |
| 161 | negative regulation of glycogen metabolic process (GO:0070874) | 2.35575338 |
| 162 | peroxisomal transport (GO:0043574) | 2.31238276 |
| 163 | cilium movement (GO:0003341) | 2.31147283 |
| 164 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.29693060 |
| 165 | inositol phosphate dephosphorylation (GO:0046855) | 2.29693060 |
| 166 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.28057900 |
| 167 | negative regulation of neurological system process (GO:0031645) | 2.27261102 |
| 168 | determination of left/right symmetry (GO:0007368) | 2.25673008 |
| 169 | calcium ion import (GO:0070509) | 2.23857125 |
| 170 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.22769514 |
| 171 | axoneme assembly (GO:0035082) | 2.22554528 |
| 172 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.20957988 |
| 173 | middle ear morphogenesis (GO:0042474) | 2.20941241 |
| 174 | regulation of fatty acid oxidation (GO:0046320) | 2.19290741 |
| 175 | dentate gyrus development (GO:0021542) | 2.18997502 |
| 176 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.18065355 |
| 177 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.18008295 |
| 178 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.18008295 |
| 179 | lung secretory cell differentiation (GO:0061140) | 2.17739867 |
| 180 | determination of bilateral symmetry (GO:0009855) | 2.17312673 |
| 181 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.16756207 |
| 182 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.16215388 |
| 183 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.16013765 |
| 184 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.15407143 |
| 185 | vitamin biosynthetic process (GO:0009110) | 2.14917142 |
| 186 | regulation of glucokinase activity (GO:0033131) | 2.14717422 |
| 187 | regulation of hexokinase activity (GO:1903299) | 2.14717422 |
| 188 | myelin maintenance (GO:0043217) | 2.12936664 |
| 189 | pharyngeal system development (GO:0060037) | 2.12622221 |
| 190 | specification of symmetry (GO:0009799) | 2.11184287 |
| 191 | glycerophospholipid catabolic process (GO:0046475) | 2.10450556 |
| 192 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 2.09804157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.37751140 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.05466946 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.81168837 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.07247169 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73507898 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.68095802 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.60529922 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59955664 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36993923 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30311220 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30311220 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.28800691 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19174880 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18583313 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18481821 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.17757224 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15902211 |
| 18 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.15217094 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10697052 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05120293 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.04034790 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01954939 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00846035 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98475414 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.89588885 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84466698 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83147889 |
| 28 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.82364606 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81647258 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80242493 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77156956 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74888599 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74774413 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73462271 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73290291 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.70314554 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65629320 |
| 38 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.62541605 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.61075254 |
| 40 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61054130 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59049204 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58223639 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56764566 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.56701785 |
| 45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.55320337 |
| 46 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53664009 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53335741 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48432046 |
| 49 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48127055 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46915582 |
| 51 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45524890 |
| 52 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.44015788 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.43459323 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42648000 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41975011 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41975011 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41257442 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40495919 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38505568 |
| 60 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37078789 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37017789 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35442734 |
| 63 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32977028 |
| 64 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32903345 |
| 65 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31486319 |
| 66 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.30973638 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.28700258 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.28700258 |
| 69 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26444232 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25748817 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25389242 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23516407 |
| 73 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23312442 |
| 74 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22754592 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21861965 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.21708902 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19373457 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19299573 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18946088 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18665407 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17445613 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17326091 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16399150 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16380543 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16330389 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16182429 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14537922 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13654504 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 1.13170706 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12959327 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12649942 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12571932 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12364408 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12199681 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11953028 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11824531 |
| 97 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11532227 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09822058 |
| 99 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09804721 |
| 100 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.09297831 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08029669 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07417865 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07183827 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07073444 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07027801 |
| 106 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06626828 |
| 107 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05714693 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 1.05347312 |
| 109 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05169723 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04442797 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04367255 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04367255 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03709956 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02504172 |
| 115 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02088037 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02073836 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00807228 |
| 118 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.99979667 |
| 119 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99953541 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99600046 |
| 121 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99068851 |
| 122 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98785722 |
| 123 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97702192 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97322374 |
| 125 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97304381 |
| 126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97300595 |
| 127 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.96931686 |
| 128 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96714991 |
| 129 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95893014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.14770490 |
| 2 | MP0003646_muscle_fatigue | 4.65964888 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.49858805 |
| 4 | MP0003880_abnormal_central_pattern | 3.52881743 |
| 5 | MP0004270_analgesia | 3.23557214 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.14466832 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.00853372 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.62378244 |
| 9 | MP0009745_abnormal_behavioral_response | 2.49277045 |
| 10 | MP0003195_calcinosis | 2.46804256 |
| 11 | MP0005503_abnormal_tendon_morphology | 2.43674299 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.39246461 |
| 13 | MP0002064_seizures | 2.32477541 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.28934517 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.28833284 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.28706730 |
| 17 | MP0009046_muscle_twitch | 2.22074267 |
| 18 | MP0000778_abnormal_nervous_system | 2.17194723 |
| 19 | MP0008775_abnormal_heart_ventricle | 2.13654816 |
| 20 | MP0003122_maternal_imprinting | 2.11824796 |
| 21 | MP0001486_abnormal_startle_reflex | 2.11369093 |
| 22 | MP0002272_abnormal_nervous_system | 2.04501738 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.98408715 |
| 24 | MP0003283_abnormal_digestive_organ | 1.84330537 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.77760916 |
| 26 | MP0000537_abnormal_urethra_morphology | 1.77100227 |
| 27 | MP0002184_abnormal_innervation | 1.73208129 |
| 28 | MP0009384_cardiac_valve_regurgitation | 1.71418048 |
| 29 | MP0004130_abnormal_muscle_cell | 1.69081292 |
| 30 | MP0003787_abnormal_imprinting | 1.69050828 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.68345110 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.66660341 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.65341685 |
| 34 | MP0001188_hyperpigmentation | 1.64185765 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.63929765 |
| 36 | MP0000955_abnormal_spinal_cord | 1.62697078 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.60464222 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.59200238 |
| 39 | MP0004885_abnormal_endolymph | 1.57373883 |
| 40 | MP0001970_abnormal_pain_threshold | 1.56271476 |
| 41 | MP0003011_delayed_dark_adaptation | 1.55407105 |
| 42 | MP0005670_abnormal_white_adipose | 1.51635101 |
| 43 | MP0001984_abnormal_olfaction | 1.47778871 |
| 44 | MP0002928_abnormal_bile_duct | 1.45602903 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.45079302 |
| 46 | MP0000631_abnormal_neuroendocrine_gland | 1.43324784 |
| 47 | MP0002736_abnormal_nociception_after | 1.39503858 |
| 48 | MP0001270_distended_abdomen | 1.38692656 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.38254988 |
| 50 | MP0003121_genomic_imprinting | 1.36720359 |
| 51 | MP0004924_abnormal_behavior | 1.36598335 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.36598335 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.35741525 |
| 54 | MP0001756_abnormal_urination | 1.35379379 |
| 55 | MP0004043_abnormal_pH_regulation | 1.35318365 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.35103306 |
| 57 | MP0000569_abnormal_digit_pigmentation | 1.34614884 |
| 58 | MP0004858_abnormal_nervous_system | 1.34072451 |
| 59 | MP0006276_abnormal_autonomic_nervous | 1.34043034 |
| 60 | MP0005171_absent_coat_pigmentation | 1.33371329 |
| 61 | MP0003123_paternal_imprinting | 1.31432035 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.31120785 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.30760499 |
| 64 | MP0000538_abnormal_urinary_bladder | 1.29764607 |
| 65 | MP0001299_abnormal_eye_distance/ | 1.28784520 |
| 66 | MP0008569_lethality_at_weaning | 1.28440324 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.28214032 |
| 68 | MP0003329_amyloid_beta_deposits | 1.26804488 |
| 69 | MP0001529_abnormal_vocalization | 1.23871183 |
| 70 | MP0001944_abnormal_pancreas_morphology | 1.21705013 |
| 71 | MP0005499_abnormal_olfactory_system | 1.21614632 |
| 72 | MP0005394_taste/olfaction_phenotype | 1.21614632 |
| 73 | MP0004185_abnormal_adipocyte_glucose | 1.19910079 |
| 74 | MP0002152_abnormal_brain_morphology | 1.19879886 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.19457924 |
| 76 | MP0000230_abnormal_systemic_arterial | 1.18964212 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.18737807 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 1.17370877 |
| 79 | MP0003879_abnormal_hair_cell | 1.17252542 |
| 80 | MP0002160_abnormal_reproductive_system | 1.16633599 |
| 81 | MP0001958_emphysema | 1.16561805 |
| 82 | MP0001177_atelectasis | 1.11410037 |
| 83 | MP0004742_abnormal_vestibular_system | 1.08534337 |
| 84 | MP0001905_abnormal_dopamine_level | 1.08092276 |
| 85 | MP0008877_abnormal_DNA_methylation | 1.06213184 |
| 86 | MP0006072_abnormal_retinal_apoptosis | 1.04404693 |
| 87 | MP0000013_abnormal_adipose_tissue | 1.03421470 |
| 88 | MP0004142_abnormal_muscle_tone | 1.02921075 |
| 89 | MP0002638_abnormal_pupillary_reflex | 1.01690152 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 1.01291004 |
| 91 | MP0002168_other_aberrant_phenotype | 1.00896879 |
| 92 | MP0003634_abnormal_glial_cell | 1.00205159 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.99768821 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.99208674 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.98342283 |
| 96 | MP0000516_abnormal_urinary_system | 0.98342283 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.98263587 |
| 98 | MP0000920_abnormal_myelination | 0.97778114 |
| 99 | MP0005332_abnormal_amino_acid | 0.96011107 |
| 100 | MP0003861_abnormal_nervous_system | 0.95475114 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.92494405 |
| 102 | MP0003633_abnormal_nervous_system | 0.90496699 |
| 103 | MP0010329_abnormal_lipoprotein_level | 0.90491942 |
| 104 | MP0003252_abnormal_bile_duct | 0.89625333 |
| 105 | MP0005551_abnormal_eye_electrophysiolog | 0.88370620 |
| 106 | MP0002295_abnormal_pulmonary_circulatio | 0.87207071 |
| 107 | MP0002752_abnormal_somatic_nervous | 0.87021510 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.86446689 |
| 109 | MP0010352_gastrointestinal_tract_polyps | 0.86179028 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.84706737 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 0.84136822 |
| 112 | MP0003631_nervous_system_phenotype | 0.83782854 |
| 113 | MP0003632_abnormal_nervous_system | 0.83689760 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.83537965 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.83511490 |
| 116 | MP0003119_abnormal_digestive_system | 0.83389115 |
| 117 | MP0003755_abnormal_palate_morphology | 0.83059441 |
| 118 | MP0000427_abnormal_hair_cycle | 0.83032229 |
| 119 | MP0000026_abnormal_inner_ear | 0.82634358 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.81599900 |
| 121 | MP0005220_abnormal_exocrine_pancreas | 0.81560809 |
| 122 | MP0002233_abnormal_nose_morphology | 0.81190992 |
| 123 | MP0003938_abnormal_ear_development | 0.80956549 |
| 124 | MP0005187_abnormal_penis_morphology | 0.78995533 |
| 125 | MP0002229_neurodegeneration | 0.78850809 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.78702080 |
| 127 | MP0005408_hypopigmentation | 0.78600294 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.78238553 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.77554878 |
| 130 | MP0002751_abnormal_autonomic_nervous | 0.77232386 |
| 131 | MP0001661_extended_life_span | 0.77213218 |
| 132 | MP0004133_heterotaxia | 0.76813336 |
| 133 | MP0005409_darkened_coat_color | 0.74792045 |
| 134 | MP0004134_abnormal_chest_morphology | 0.72943401 |
| 135 | MP0003937_abnormal_limbs/digits/tail_de | 0.71905057 |
| 136 | MP0002102_abnormal_ear_morphology | 0.71892679 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.71770456 |
| 138 | MP0009250_abnormal_appendicular_skeleto | 0.71231919 |
| 139 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70436854 |
| 140 | MP0003942_abnormal_urinary_system | 0.70208926 |
| 141 | MP0003953_abnormal_hormone_level | 0.69970127 |
| 142 | MP0002938_white_spotting | 0.69883242 |
| 143 | MP0005253_abnormal_eye_physiology | 0.69321878 |
| 144 | MP0004233_abnormal_muscle_weight | 0.69314970 |
| 145 | MP0001943_abnormal_respiration | 0.69278832 |
| 146 | MP0004085_abnormal_heartbeat | 0.69139465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Meningioma (HP:0002858) | 5.69513912 |
| 2 | Focal motor seizures (HP:0011153) | 4.66094201 |
| 3 | Methylmalonic acidemia (HP:0002912) | 3.78850654 |
| 4 | Epileptic encephalopathy (HP:0200134) | 3.67922045 |
| 5 | Lymphangioma (HP:0100764) | 3.66568320 |
| 6 | Focal seizures (HP:0007359) | 3.64429139 |
| 7 | Hyperglycinemia (HP:0002154) | 3.42821435 |
| 8 | Methylmalonic aciduria (HP:0012120) | 3.38305899 |
| 9 | Asymmetry of the thorax (HP:0001555) | 3.36683539 |
| 10 | Enlarged penis (HP:0000040) | 3.32774491 |
| 11 | Atonic seizures (HP:0010819) | 3.24037094 |
| 12 | Myokymia (HP:0002411) | 3.22383156 |
| 13 | Visual hallucinations (HP:0002367) | 3.13440640 |
| 14 | Progressive cerebellar ataxia (HP:0002073) | 3.12263250 |
| 15 | Cardiovascular calcification (HP:0011915) | 2.97309921 |
| 16 | Neoplasm of the lung (HP:0100526) | 2.91183439 |
| 17 | Hematochezia (HP:0002573) | 2.87509371 |
| 18 | Benign neoplasm of the central nervous system (HP:0100835) | 2.84755215 |
| 19 | Vascular calcification (HP:0004934) | 2.83827018 |
| 20 | Absence seizures (HP:0002121) | 2.79962005 |
| 21 | Broad-based gait (HP:0002136) | 2.77338750 |
| 22 | Melanoma (HP:0002861) | 2.73943620 |
| 23 | Febrile seizures (HP:0002373) | 2.73570948 |
| 24 | Exostoses (HP:0100777) | 2.63968568 |
| 25 | Gait imbalance (HP:0002141) | 2.62999419 |
| 26 | Conjunctival hamartoma (HP:0100780) | 2.62552387 |
| 27 | Dialeptic seizures (HP:0011146) | 2.57155651 |
| 28 | Action tremor (HP:0002345) | 2.56030853 |
| 29 | Excessive salivation (HP:0003781) | 2.54339903 |
| 30 | Drooling (HP:0002307) | 2.54339903 |
| 31 | Congenital glaucoma (HP:0001087) | 2.53550544 |
| 32 | Abnormality of vitamin B metabolism (HP:0004340) | 2.49261937 |
| 33 | Generalized tonic-clonic seizures (HP:0002069) | 2.48806971 |
| 34 | Neoplasm of the respiratory system (HP:0100606) | 2.39279521 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.37718518 |
| 36 | Hamartoma of the eye (HP:0010568) | 2.37231399 |
| 37 | Insidious onset (HP:0003587) | 2.36976940 |
| 38 | Termporal pattern (HP:0011008) | 2.36976940 |
| 39 | Abnormality of the corticospinal tract (HP:0002492) | 2.34939090 |
| 40 | Truncal ataxia (HP:0002078) | 2.33552773 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.32552380 |
| 42 | Rhinitis (HP:0012384) | 2.31805301 |
| 43 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.30546456 |
| 44 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.30546456 |
| 45 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.28741402 |
| 46 | Ankle clonus (HP:0011448) | 2.28728872 |
| 47 | Papilledema (HP:0001085) | 2.28393507 |
| 48 | Ketosis (HP:0001946) | 2.27494191 |
| 49 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.27368666 |
| 50 | Torticollis (HP:0000473) | 2.26616161 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.26530655 |
| 52 | Irregular vertebral endplates (HP:0003301) | 2.24613310 |
| 53 | Aortic aneurysm (HP:0004942) | 2.24159473 |
| 54 | Genetic anticipation (HP:0003743) | 2.23044993 |
| 55 | Bone cyst (HP:0012062) | 2.22802475 |
| 56 | Retinal dysplasia (HP:0007973) | 2.22673796 |
| 57 | Goiter (HP:0000853) | 2.22576619 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.22446675 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.22391098 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.22391098 |
| 61 | Hyperventilation (HP:0002883) | 2.21887450 |
| 62 | Megalencephaly (HP:0001355) | 2.21856078 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.21847036 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.20507139 |
| 65 | Ovoid vertebral bodies (HP:0003300) | 2.17585287 |
| 66 | Genital tract atresia (HP:0001827) | 2.17463741 |
| 67 | Subacute progressive viral hepatitis (HP:0006572) | 2.17061454 |
| 68 | Abnormality of vitamin metabolism (HP:0100508) | 2.15769296 |
| 69 | Neurofibrillary tangles (HP:0002185) | 2.15549058 |
| 70 | Delayed gross motor development (HP:0002194) | 2.14865449 |
| 71 | Neoplasm of the adrenal gland (HP:0100631) | 2.14388478 |
| 72 | Limb dystonia (HP:0002451) | 2.13931528 |
| 73 | Vaginal atresia (HP:0000148) | 2.13127423 |
| 74 | Testicular neoplasm (HP:0010788) | 2.11521931 |
| 75 | Nephronophthisis (HP:0000090) | 2.10323923 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.10014315 |
| 77 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08735689 |
| 78 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08735689 |
| 79 | Ketoacidosis (HP:0001993) | 2.08685680 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 2.08646048 |
| 81 | Aortic dissection (HP:0002647) | 2.07955988 |
| 82 | Dysdiadochokinesis (HP:0002075) | 2.07758664 |
| 83 | Hyperkalemia (HP:0002153) | 2.06114348 |
| 84 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.05942563 |
| 85 | Vascular tortuosity (HP:0004948) | 2.05475195 |
| 86 | Agitation (HP:0000713) | 2.02963958 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.02893178 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.01122925 |
| 89 | True hermaphroditism (HP:0010459) | 2.01099733 |
| 90 | Increased circulating renin level (HP:0000848) | 2.00401652 |
| 91 | Cutaneous melanoma (HP:0012056) | 11.0721052 |
| 92 | Hepatoblastoma (HP:0002884) | 1.99109152 |
| 93 | Protruding tongue (HP:0010808) | 1.98267029 |
| 94 | Short femoral neck (HP:0100864) | 1.97779009 |
| 95 | Depression (HP:0000716) | 1.95994340 |
| 96 | Congenital sensorineural hearing impairment (HP:0008527) | 1.94402798 |
| 97 | Poor eye contact (HP:0000817) | 1.94364616 |
| 98 | Dysmetria (HP:0001310) | 1.94106375 |
| 99 | Mitral stenosis (HP:0001718) | 1.94104601 |
| 100 | Abnormality of the labia minora (HP:0012880) | 1.93978106 |
| 101 | Nephrogenic diabetes insipidus (HP:0009806) | 1.93896294 |
| 102 | Visceral angiomatosis (HP:0100761) | 1.93532946 |
| 103 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93394531 |
| 104 | Coronal craniosynostosis (HP:0004440) | 1.90874196 |
| 105 | Papillary thyroid carcinoma (HP:0002895) | 1.90798857 |
| 106 | Amblyopia (HP:0000646) | 1.90458427 |
| 107 | Fibular hypoplasia (HP:0003038) | 1.90269138 |
| 108 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90106206 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90106206 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90106206 |
| 111 | Hyperthyroidism (HP:0000836) | 1.87945749 |
| 112 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.87910527 |
| 113 | Arterial tortuosity (HP:0005116) | 1.87566018 |
| 114 | Hypothermia (HP:0002045) | 1.85971448 |
| 115 | Amyotrophic lateral sclerosis (HP:0007354) | 1.85835372 |
| 116 | Short tibia (HP:0005736) | 1.83813052 |
| 117 | Abnormality of the renal medulla (HP:0100957) | 1.83110349 |
| 118 | Pheochromocytoma (HP:0002666) | 1.82716972 |
| 119 | Hemiparesis (HP:0001269) | 1.82437644 |
| 120 | Bronchomalacia (HP:0002780) | 1.82390934 |
| 121 | Specific learning disability (HP:0001328) | 1.81850081 |
| 122 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.81565565 |
| 123 | Aqueductal stenosis (HP:0002410) | 1.81238124 |
| 124 | Absent speech (HP:0001344) | 1.81202247 |
| 125 | Anxiety (HP:0000739) | 1.80979972 |
| 126 | Scanning speech (HP:0002168) | 1.80941329 |
| 127 | Lower limb asymmetry (HP:0100559) | 1.80766873 |
| 128 | Genu recurvatum (HP:0002816) | 1.80058221 |
| 129 | Type II lissencephaly (HP:0007260) | 1.79822045 |
| 130 | Spastic gait (HP:0002064) | 1.79777504 |
| 131 | Impaired smooth pursuit (HP:0007772) | 1.79322680 |
| 132 | Mutism (HP:0002300) | 1.79244312 |
| 133 | Akinesia (HP:0002304) | 1.78140991 |
| 134 | Abnormal eating behavior (HP:0100738) | 1.77569171 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.76723011 |
| 136 | Spinal cord compression (HP:0002176) | 1.76617494 |
| 137 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.75837089 |
| 138 | Aplasia of the phalanges of the hand (HP:0009802) | 1.75837089 |
| 139 | Aplasia involving bones of the extremities (HP:0009825) | 1.75837089 |
| 140 | Blue irides (HP:0000635) | 1.75669001 |
| 141 | Hemangiomatosis (HP:0007461) | 1.75487571 |
| 142 | Postural instability (HP:0002172) | 1.75463854 |
| 143 | Urinary urgency (HP:0000012) | 1.74014383 |
| 144 | Morphological abnormality of the middle ear (HP:0008609) | 1.73625540 |
| 145 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.73375083 |
| 146 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73275311 |
| 147 | Thyroiditis (HP:0100646) | 1.72096921 |
| 148 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.71638867 |
| 149 | Hypoplasia of the uterus (HP:0000013) | 1.71343799 |
| 150 | Epiphyseal dysplasia (HP:0002656) | 1.71296678 |
| 151 | Dysostosis multiplex (HP:0000943) | 1.70869928 |
| 152 | Abnormality of salivation (HP:0100755) | 1.68261245 |
| 153 | Furrowed tongue (HP:0000221) | 1.67924280 |
| 154 | Decreased circulating renin level (HP:0003351) | 1.66153195 |
| 155 | Gastroesophageal reflux (HP:0002020) | 1.66012594 |
| 156 | Abnormality of potassium homeostasis (HP:0011042) | 1.65079597 |
| 157 | Pancreatic fibrosis (HP:0100732) | 1.65009034 |
| 158 | Limited hip movement (HP:0008800) | 1.64867495 |
| 159 | Stereotypic behavior (HP:0000733) | 1.64709036 |
| 160 | Hypoplasia of the odontoid process (HP:0003311) | 1.64625317 |
| 161 | Buphthalmos (HP:0000557) | 1.63385169 |
| 162 | Absent/shortened dynein arms (HP:0200106) | 1.63153026 |
| 163 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.63153026 |
| 164 | Mild short stature (HP:0003502) | 1.62968511 |
| 165 | Abnormal ciliary motility (HP:0012262) | 1.62899399 |
| 166 | Lower limb muscle weakness (HP:0007340) | 1.62355564 |
| 167 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.61973345 |
| 168 | Abnormality of dentin (HP:0010299) | 1.60855493 |
| 169 | Open mouth (HP:0000194) | 1.60774578 |
| 170 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.60023961 |
| 171 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.59311173 |
| 172 | Widely spaced teeth (HP:0000687) | 1.57818527 |
| 173 | Relative macrocephaly (HP:0004482) | 1.57337774 |
| 174 | Impaired social interactions (HP:0000735) | 1.57181111 |
| 175 | Abnormal social behavior (HP:0012433) | 1.57181111 |
| 176 | Intention tremor (HP:0002080) | 1.56251155 |
| 177 | Neoplasm of the adrenal cortex (HP:0100641) | 1.56165262 |
| 178 | Poor coordination (HP:0002370) | 1.55886412 |
| 179 | Absent eyebrow (HP:0002223) | 1.55272910 |
| 180 | Macroorchidism (HP:0000053) | 1.53847316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.09002990 |
| 2 | NTRK3 | 4.04335187 |
| 3 | EPHA4 | 3.09434420 |
| 4 | MAP3K4 | 2.91431792 |
| 5 | CASK | 2.60992884 |
| 6 | PNCK | 2.53992452 |
| 7 | MAP3K9 | 2.50174069 |
| 8 | MAP2K7 | 2.47031818 |
| 9 | MAP3K13 | 2.40955536 |
| 10 | MINK1 | 2.11193275 |
| 11 | NTRK2 | 2.02105293 |
| 12 | FGFR3 | 1.98284890 |
| 13 | PLK2 | 1.96514679 |
| 14 | TNIK | 1.95836612 |
| 15 | PRKD3 | 1.90024875 |
| 16 | NTRK1 | 1.84097714 |
| 17 | MAP3K2 | 1.60500032 |
| 18 | UHMK1 | 1.58836068 |
| 19 | PAK6 | 1.58281138 |
| 20 | MYLK | 1.54989006 |
| 21 | MAPK13 | 1.53179056 |
| 22 | BCR | 1.52621626 |
| 23 | OXSR1 | 1.45503919 |
| 24 | STK39 | 1.43250577 |
| 25 | KSR1 | 1.40586060 |
| 26 | WNK3 | 1.39835389 |
| 27 | CDK5 | 1.37308791 |
| 28 | STK38L | 1.30424241 |
| 29 | GRK1 | 1.29551747 |
| 30 | PRPF4B | 1.28191469 |
| 31 | DAPK2 | 1.25300625 |
| 32 | CSNK1G2 | 1.25214368 |
| 33 | LATS1 | 1.21292285 |
| 34 | MAP2K4 | 1.17628616 |
| 35 | MAP4K2 | 1.15659298 |
| 36 | NEK9 | 1.14888544 |
| 37 | ADRBK2 | 1.14218819 |
| 38 | PAK3 | 1.13361050 |
| 39 | EPHB2 | 1.13046866 |
| 40 | AKT3 | 1.12746971 |
| 41 | SCYL2 | 1.12437235 |
| 42 | SGK494 | 1.10742605 |
| 43 | SGK223 | 1.10742605 |
| 44 | WNK4 | 1.10729445 |
| 45 | FGFR2 | 1.08207098 |
| 46 | CAMK2B | 1.08141682 |
| 47 | WNK1 | 1.07444520 |
| 48 | PRKCG | 1.06737965 |
| 49 | ERBB3 | 1.06376490 |
| 50 | DDR2 | 1.02825735 |
| 51 | CAMK2A | 1.02402819 |
| 52 | TYRO3 | 1.01515048 |
| 53 | ACVR1B | 0.99891699 |
| 54 | PTK2B | 0.99887871 |
| 55 | CDK19 | 0.98981205 |
| 56 | MAPK15 | 0.97838003 |
| 57 | CSNK1A1L | 0.95633784 |
| 58 | MAP3K12 | 0.94619173 |
| 59 | DYRK1A | 0.93681614 |
| 60 | JAK1 | 0.92384893 |
| 61 | LATS2 | 0.89687778 |
| 62 | EPHA3 | 0.87735821 |
| 63 | CDK14 | 0.87049531 |
| 64 | GRK5 | 0.85653246 |
| 65 | TRPM7 | 0.85521624 |
| 66 | KSR2 | 0.85123770 |
| 67 | PHKG1 | 0.84274805 |
| 68 | PHKG2 | 0.84274805 |
| 69 | ROCK1 | 0.83999631 |
| 70 | NEK6 | 0.83335806 |
| 71 | PRKD2 | 0.82975142 |
| 72 | ADRBK1 | 0.82413827 |
| 73 | DAPK1 | 0.82384839 |
| 74 | CSNK1G3 | 0.82173198 |
| 75 | CAMKK1 | 0.82031236 |
| 76 | SGK2 | 0.81528568 |
| 77 | PRKCE | 0.81329397 |
| 78 | CDK18 | 0.80063274 |
| 79 | DYRK2 | 0.79197904 |
| 80 | RET | 0.76508451 |
| 81 | CDK15 | 0.76261524 |
| 82 | FRK | 0.72370193 |
| 83 | MAP3K7 | 0.70106706 |
| 84 | INSRR | 0.69385485 |
| 85 | PRKAA2 | 0.68637748 |
| 86 | CAMK2D | 0.68235935 |
| 87 | SGK1 | 0.68204605 |
| 88 | MST4 | 0.66786058 |
| 89 | MKNK2 | 0.65918413 |
| 90 | TGFBR2 | 0.65697964 |
| 91 | FER | 0.65009992 |
| 92 | MAP3K14 | 0.63943371 |
| 93 | CDK11A | 0.63709063 |
| 94 | CAMKK2 | 0.61991560 |
| 95 | PKN2 | 0.61265974 |
| 96 | CDC42BPA | 0.61160787 |
| 97 | TAOK3 | 0.60847838 |
| 98 | MARK2 | 0.59825122 |
| 99 | ROCK2 | 0.59319164 |
| 100 | STK3 | 0.58855979 |
| 101 | PLK3 | 0.58328457 |
| 102 | CSNK1G1 | 0.57428662 |
| 103 | PASK | 0.56607833 |
| 104 | PINK1 | 0.56356879 |
| 105 | PRKCH | 0.56229715 |
| 106 | BMPR2 | 0.55126316 |
| 107 | ALK | 0.54987691 |
| 108 | ERBB2 | 0.54664874 |
| 109 | PIK3CA | 0.54266619 |
| 110 | STK11 | 0.53332928 |
| 111 | MAPK10 | 0.52831883 |
| 112 | MET | 0.52236104 |
| 113 | LMTK2 | 0.51968591 |
| 114 | BCKDK | 0.51775639 |
| 115 | SGK3 | 0.51566327 |
| 116 | STK38 | 0.48786165 |
| 117 | CAMK1G | 0.48146887 |
| 118 | CSNK1E | 0.44511210 |
| 119 | FGR | 0.44363636 |
| 120 | MAP2K6 | 0.43796969 |
| 121 | PTK2 | 0.42365069 |
| 122 | RPS6KA3 | 0.41854835 |
| 123 | PDGFRB | 0.40923047 |
| 124 | HIPK2 | 0.40645251 |
| 125 | PRKCQ | 0.40638535 |
| 126 | SIK2 | 0.40567238 |
| 127 | BMPR1B | 0.40423995 |
| 128 | PRKCZ | 0.40238746 |
| 129 | LIMK1 | 0.39932059 |
| 130 | MAPKAPK5 | 0.39854964 |
| 131 | TIE1 | 0.39283893 |
| 132 | ILK | 0.38634409 |
| 133 | CAMK2G | 0.38361269 |
| 134 | PKN1 | 0.38272615 |
| 135 | NLK | 0.37622699 |
| 136 | CSNK1A1 | 0.37421495 |
| 137 | RIPK4 | 0.37240741 |
| 138 | CAMK1 | 0.37119406 |
| 139 | MKNK1 | 0.36632214 |
| 140 | CSNK1D | 0.36084842 |
| 141 | PRKG2 | 0.34013140 |
| 142 | PRKG1 | 0.33749676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.50920749 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.42695133 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56729912 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54821087 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.48626194 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.46706686 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43005265 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.35643957 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.27572250 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.26735814 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.11789415 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09092228 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.04182000 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91185149 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.84339003 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.80983753 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.75240773 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74454372 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.72029779 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70798162 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.70413391 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.65945939 |
| 23 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.61628588 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.59496185 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.54239023 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.52690621 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.51710904 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44767911 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38794690 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.37562100 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37107302 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37037371 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34521749 |
| 34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34189894 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.33395731 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30157776 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.29941932 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29094170 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20350918 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.20265224 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19231245 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.19171615 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18589942 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14699197 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12404747 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11931362 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10489388 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10280115 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10204879 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.08838192 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.08332120 |
| 52 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.05273257 |
| 53 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03741722 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03201561 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02140077 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99754099 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97192065 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.95127592 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94278150 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92884204 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92741662 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92741300 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90690064 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90248337 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89621788 |
| 66 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.89446984 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89202538 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88759155 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88674111 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88202084 |
| 71 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.87773258 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.86910070 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.86168099 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84966833 |
| 75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.84143907 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82473420 |
| 77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81867272 |
| 78 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.81763765 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81127139 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80221837 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79526535 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78676253 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78503874 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78027569 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77692179 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77500171 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76316361 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75408872 |
| 89 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75342423 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74902953 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73998543 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73819770 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73550762 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73363363 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73116011 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71439996 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70935161 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70823256 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.69258852 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68866293 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68569143 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68472273 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68244381 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67287479 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67132924 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.66920283 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66806904 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.66089036 |
| 109 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66007961 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64787898 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64117975 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63622017 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63046603 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62928958 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62546449 |
| 116 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61385417 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59465485 |
| 118 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.59323100 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59060468 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56568191 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56326801 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56225825 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54264288 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53562612 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51477223 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49518721 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46332966 |
| 128 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46169891 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.45937471 |
| 130 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45880931 |
| 131 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.44416263 |
| 132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44287493 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43834158 |
| 134 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43657252 |
| 135 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43522417 |
| 136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41064252 |
| 137 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40923887 |
| 138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40775983 |
| 139 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40722383 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39373794 |
| 141 | Prostate cancer_Homo sapiens_hsa05215 | 0.38752766 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.38385727 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37921808 |

